CRON Q2 2024 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+46.0% YoY

Gross Profit

$6M22.7% margin

Operating Income

-$16M-56.1% margin

Net Income

-$9M-31.5% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+9.8%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$828,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$35M

Stockholders' Equity

$1.1B

Cash & Equivalents

$848M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$19M	+46.0%
Gross Profit	$6M	$3M	+103.2%
Operating Income	-$16M	-$21M	+24.5%
Net Income	-$9M	-$8M	-4.7%